Credit: Cargolux

Luxembourg-based all-cargo airline Cargolux and logistics provider DB Schenker have announced a new full charter cargo connection between Luxembourg and Indianapolis in the USA, starting in January 2021.

With this new agreement, both partners are expanding their well-established fifteen year-long partnership. Cargolux’s initial service between its home base in Luxembourg and the Indiana capital was inaugurated in 2005 to support DB Schenker’s business in the region. The successful collaboration has grown over the years and is now cemented through this charter solution.

With weekly departures on a Boeing 747 freighter, DB Schenker will make Cargolux’s extensive experience in the handling of pharmaceutical and healthcare goods available for its customers in Europe and Northern America. By partnering with the leading provider of transportation services for pharmaceutical and healthcare products and the airline that was, in 2014, the first to be GDP certified, DB Schenker has reached a milestone in setting up its new healthcare service portfolio, DB SCHENKERlife+.

Veronique Dameme, Head of Global Vertical Market Healthcare at DB Schenker, commented: “Our new product portfolio DB SCHENKERlife+ offers exceptional quality, unconditional security and fully reliable logistics services. The cooperation with Cargolux expands the foundation for our robust global GDP programme and customised services as air track, 24/7 monitoring, packaging supplies or telemetric devices. In such volatile times DB SCHENKERlife+ thus provides urgently needed transparency and predictability”.

Domenico Ceci, Cargolux’s Executive Vice-President Sales & Marketing, added: “Cargolux is pleased to launch this new weekly charter service in collaboration with DB Schenker. Both companies have enjoyed a fruitful and mutually beneficial partnership on this lane over the past fifteen years and we are happy to expand on this success”.

The new weekly connection between Luxembourg and Indianapolis will make DB Schenker’s portfolio of customizable services available in the world’s regions with the highest demand for healthcare and pharmaceutical products and will create capacities for potential COVID-19 vaccine transportation demand.